In glioblastoma, for example, reduced signaling resulting in diminished pERK phosphorylation was observed as a result of Spry4 expression, but Spry3 exerted tumor-promoting activities without influencing these pathways [30]. This evidence concerns the gene SPRY3 and neoplasm.